Serum WFA(+) -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
about
Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients.Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure
P2860
Serum WFA(+) -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Serum WFA(+) -M2BP levels pred ...... all survival: A meta-analysis.
@en
type
label
Serum WFA(+) -M2BP levels pred ...... all survival: A meta-analysis.
@en
prefLabel
Serum WFA(+) -M2BP levels pred ...... all survival: A meta-analysis.
@en
P2093
P2860
P356
P1476
Serum WFA(+) -M2BP levels pred ...... all survival: A meta-analysis.
@en
P2093
Haruhisa Nakao
Kenta Murotani
Kiyoaki Ito
Masashi Yoneda
Tadahisa Inoue
Yoshihiro Kamada
Yoshio Sumida
Yukiomi Nakade
P2860
P356
10.1111/JGH.13802
P577
2017-04-12T00:00:00Z